Publication | Open Access

The conundrum of using hyperoxia in COVID-19 treatment strategies: may intermittent therapeutic hyperoxia play a helpful role in the expression of the surface receptors ACE2 and Furin in lung tissue via triggering of HIF-1α?

InflammationInflammatory Lung DiseaseLung InflammationMedicineImmunologyTherapeutic HyperoxiaPulmonary PhysiologyLung MechanicsTissue OxygenationReactive Oxygen SpecieSurface Receptors Ace2PharmacologyOxidative StressLung Tissue